期刊文献+

雄激素受体基因对人膀胱癌T24细胞黏附和侵袭力的影响 被引量:2

Effects of androgen receptor gene on adhesion and invasion of human bladder cancer T24 cells
原文传递
导出
摘要 目的观察雄激素受体(AR)基因小干扰RNA(siRNA)对膀胱癌黏附和侵袭力的影响。方法采用AR基因siRNA转染膀胱癌T24细胞,分别应用实时定量聚合酶链反应(Real-time PCR)和Western blot检测AR mRNA和蛋白表达水平的变化。转染T24细胞后用噻唑蓝(MTT)比色法检测细胞黏附性,用Transwell方法检测细胞侵袭能力。结果AR—siRNA成功转染膀胱癌T24细胞后,T24细胞AR基因mRNA和蛋白表达水平明显下调。黏附实验结果显示,AR-siRNA转染组细胞黏附率为(38.7±4.4)%,显著低于空白对照组(P〈0.05);Transwell实验结果显示,AR—siRNA转染组穿膜细胞数为(30.5±6.7)个,空白对照组穿膜细胞数为(59.2±8.1)个(P〈0.05)。结论AR基因在膀胱癌黏附和侵袭中发挥重要作用,以siRNA转染膀胱癌细胞,可以抑制膀胱癌细胞的黏附和侵袭能力。 Objective To study the effects of androgen receptor (AR) gene small interfering RNA (siRNA) on adhesion and invasion of human bladder cancer cells. Methods Human bladder cancer q'24 cells with AR expression were transfected with AR-siRNA. The expression of AR mRNA and protein was detected by using real-time quantitative polymerase chain reaction (Real-time PCR) and Western blotting, respectively. The cell adhesion was evaluated by using methyl thiazol tetrazolium (MTF) assay, and inva- sion was examined by Transwell chamber. Results T24 cells with AR expression were successfully transfected with AR-siRNA. The Real-time PCR and Western blotting revealed that the expression of AR mRNA and protein was reduced. The adhesive rate in AR-siRNA group was (38.7 ± 4. 4) %, lower than that in blank control group (P 〈 0. 05 ). The Transwell results showed that the invasion cells were (30. 5 ± 6. 7 ) and (59. 2 ± 8.1 ) in AR-siRNA and blank control groups, respectively ( P 〈 0. 05 ). Conclusion AR gene might play an important role in adhesion and invasion of human bladder cancer cells, siRNA targeted AR could effectively inhibit adhesion and invasion of human bladder cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第5期1007-1009,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:山东省中青年科学家科研奖励基金资助项目(BS2011Y-Y063) 山东省医药卫生科技发展计划资助项目(2011QZ030)
关键词 膀胱癌 雄激素受体 RNA干扰 侵袭 Bladder carcinoma Androgen receptor RNA interferenee Invasion
  • 相关文献

参考文献10

  • 1Birtle AJ,Freeman A,Munson P. The androgen receptor revisited inurothelial carcinoma. Histopathology ,2004 ,45 :98-99.
  • 2刘庆祚,吴吉涛,奉友刚,王琳,门昌平,张鹏,高振利.雄激素受体在膀胱尿路上皮癌中的表达及其临床意义[J].中华实验外科杂志,2010(8):1137-1138. 被引量:4
  • 3Tuygun C, Kankaya D, Imamoglu A, et al. Sec-specific hormone re-ceptors in urothelial carcinomas of the human urinary bladder : A com-parative analysis of clinicopathological features and survival outcomesaccording to receptor expression. Urol Oncol,2011 ,29:43-51.
  • 4吴吉涛,韩邦旻,赵福军,王慧萍,李惠明,卓见,韦芳,夏术阶.小干扰RNA抑制雄激素受体基因表达对人膀胱癌T24细胞增殖及凋亡的影响[J].中华实验外科杂志,2009,26(4):502-504. 被引量:5
  • 5Wu JT,Han BM,Yu SQ,et al. Androgen receptor is a potential thera-peutic target for bladder cancer. Urology ,2010,75 :820-827.
  • 6Livak KJ,Schmittgen TD. Analysis of relative gene expression data u-sing real-time quantitative PCR and the 2(-Delta Delta C(T) ) Meth-od. Methods,2001 ,25 :402408.
  • 7赵军,童强松,陈朝晖,曾甫清,鲁功成,黄震.锤头型核酶特异性阻断雄激素受体表达对前列腺癌细胞生长的影响[J].中华实验外科杂志,2003,20(1):61-62. 被引量:3
  • 8Taneja SS,Ha S,Swenson NK,et al. Cell-specific regulation of andro-gen receptor phosphorylation in vivo. J Biol Chem,2005 ,280 :40916-40924.
  • 9Hempel N, Ye H, Abessi B, et al. Altered redox status accompaniesprogression to metastatic human bladder cancer. Free Radic BiolMed,2009,46 :42-50.
  • 10Gerhards S, Jung K,Koenig F,et al. Excretion of matrix metalloprotei-nases 2 and 9 in urine is associated with a high stage and grade ofbladder carcinoma. Urology ,2001 ,57 :675-679.

二级参考文献19

  • 1孔垂泽.膀胱癌病因学研究进展[J].中华实验外科杂志,2005,22(9):1035-1036. 被引量:9
  • 2姜泊.分子生物学常用实验方法:第2版[M].北京:人民卫生出版社,1995.101-102.
  • 3Bertram JS, Craig AW. Specific induction of bladder cancer in mice by butyl-(4-hydroxybutyl)-nitrosamine and the effects of hormonal modifications on the sex difference in response. Eur J Cancer, 1972,8: 587-594.
  • 4Miyamoto H ,Yang Z, Chen YT, ct al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst ,2007,99:558-568.
  • 5Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interferenee in cultured mammalian cells. Nature,2001,411:494-498.
  • 6Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 [ -Delta Delta C (T) ] Method. Methods ,2001,25:402-408.
  • 7Shen J, Wanibuchi H, Waalkes MP, et al. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats gender-based differences in response. Toxicol Appl Pharmacol, 2006,210 : 171-180.
  • 8Shapiro E, Huang HY, Wu XR. Uroplakin and androgen receptor expression in the human fetal genital tract:insights into the development of the vagina. J Urol,2000,164 : 1048-1051.
  • 9Zhuang YH, Blauer M, Tammela T, et al. Immunodetection of androgen receptor in human urinary bladder cancer. Histopathology, 1997, 30:556-562.
  • 10Kwong SM, Skurray RA, Firth N. Staphylococcus aureus multiresistance plasmid pSK41 :analysis of the replication region, initiator protein binding and antisense RNA regulation. Mol Microbiol, 2004,51 : 497 -509.

共引文献8

同被引文献12

  • 1Wijkstrom H,Norming U,l,agerkvist M,et al.Evaluation of cli,fical staging before cystectomy in transitional cell bladder carcinoma:a long term follow-up of 276 consecu-tive patients[J].Br J Urol,1998,81(5):686-69 1.
  • 2Sarosdy MF,White RW,Soloway MS,at al.Results of a muhi-centcr trial using the BTA test to monitor and diag-nose for recurrent bladder cancer [J].J Urol,1995,154(2 Pt 1):379-384.
  • 3Miyamoto H,Yang Z,Chen YT,et al.Promotion of bladder cancer development and progression by androgen receptor signals[J].J Natl Cancer lnst,2007,99(7):558-568.
  • 4Hueber PA,Watem P,et al.Pax2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells [J].Kidney Int,2006,69(7):1139-1145.
  • 5Johnson AM,O'Connetl MJ,Miyamoto H.et al.Andro-genic dependence of exophytic tumor growth in a trans-genic mouse model of bladder cancer:a role for throm-bospondin-1[J].BMC Urol,2008,8:7-23.
  • 6Wu JT,Han BM,Yu SQ,et al.Androgen receptor is a po-tential therapeutic target for bladder cancer [J].Urology,2010,75(4):820-827.
  • 7Li Y,Izumi K,Miyamoto H.The role of the androgen re-ceptor in the development and progression of bladder can-cer[J].Jpn J Clin Oncol,2012,42(7):569-577.
  • 8Li Y,Zheng Y,Izumi K.Androgen activates 13-catenin sig-naling in bladder cancer cells [J].Endocr Relat Cancer,2013,20(3):293-304.
  • 9Tong GX,Chiriboga L,Hamele-Bena D,et al.Expression of Pax2 in papillary serous carcinoma of the ovary:immuno-histochemical evidence of fallopian tube or seeondary Mul-lerian system origin?[J].Mod Patho1,2007,20(8):856-863.
  • 10刘庆祚,吴吉涛,奉友刚,王琳,门昌平,张鹏,高振利.雄激素受体在膀胱尿路上皮癌中的表达及其临床意义[J].中华实验外科杂志,2010(8):1137-1138. 被引量:4

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部